This study found two active isolates of immunomodulating compounds in DM infected with TB, which significantly reduced the IL-12 levels and TLR-2 protein expression, where the average decrease in IL-12 levels and TLR-2 expression was lower than that of the positive controls. This evidence concerns the gene TLR2 and tuberculosis.